You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pasireotide

Showing 1 - 25 of 80
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Post-Bariatric Hypoglycemia Trial (Pasireotide Diaspartate)

Not yet recruiting
  • Post-Bariatric Hypoglycemia
  • Pasireotide Diaspartate
  • (no location specified)
Jul 7, 2023

Gastro-enteropancreatic Neuroendocrine Tumor Trial (Pasireotide, Diazoxide)

Withdrawn
  • Gastro-enteropancreatic Neuroendocrine Tumor
  • (no location specified)
Feb 17, 2022

Enterostomy Trial in France (Pasireotide, Placebo)

Completed
  • Enterostomy
  • Pasireotide
  • Placebo
  • Amiens, France
  • +13 more
Mar 23, 2022

Neuroendocrine Tumors, Carcinoid Tumors Trial in Stanford, Tampa (Pasireotide Long Acting Release (LAR))

Active, not recruiting
Has Results
  • Neuroendocrine Tumors
  • Carcinoid Tumors
  • Pasireotide Long Acting Release (LAR)
  • Stanford, California
  • +1 more
Jan 11, 2022

Hematological Malignancies Trial in Boston, Durham (Pasireotide)

Completed
Has Results
  • Hematological Malignancies
  • Pasireotide
  • Boston, Massachusetts
  • +1 more
Oct 19, 2021

Congenital Hyperinsulinism, Insulinoma, Hyperinsulinism Trial (Pasireotide 0.6Mg Solution for Injection, Saline Solution)

Withdrawn
  • Congenital Hyperinsulinism
  • +2 more
  • Pasireotide 0.6Mg Solution for Injection
  • Saline Solution
  • (no location specified)
May 12, 2021

Pituitary Tumor, ACTH-producing Pituitary Tumour Trial in New York (Pasireotide LAR)

Terminated
Has Results
  • Pituitary Tumor
  • ACTH-producing Pituitary Tumour
  • Pasireotide LAR
  • New York, New York
    Neuroendocrine Unit and Pituitary Center, Columbia University
Mar 31, 2021

Cushing's Disease, Acromegaly, Neuroendocrine Tumors Trial in Worldwide (Pasireotide, Cabergoline)

Active, not recruiting
  • Cushing's Disease
  • +8 more
  • La Jolla, California
  • +93 more
May 19, 2022

Acromegaly Trial in Worldwide (Pasireotide)

Completed
Has Results
  • Acromegaly
  • Pasireotide
  • Los Angeles, California
  • +9 more
Sep 1, 2021

Peritoneal Carcinomatosis Trial in Villejuif (Pasireotide 0.9 MG/ML, Saline water)

Recruiting
  • Peritoneal Carcinomatosis
  • Pasireotide 0.9 MG/ML
  • Saline water
  • Villejuif, France
    Gustave Roussy
Mar 29, 2021

Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Detroit (docetaxel,

Completed
Has Results
  • Adenocarcinoma of the Prostate
  • +3 more
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Mar 2, 2021

Thyroid Cancer Trial in Atlanta, Pittsburgh (Everolimus, Pasireotide, Everolimus and Pasireotide)

Completed
Has Results
  • Thyroid Cancer
  • Atlanta, Georgia
  • +2 more
Feb 15, 2021

Metastatic Melanoma and Merkel Cell Carcinoma Trial in Essen, Lausanne, Zuerich (Pasireotide sub-cutaneous formulation,

Completed
  • Metastatic Melanoma and Merkel Cell Carcinoma
  • Pasireotide sub-cutaneous formulation
  • Pasireotide lon acting release formulation
  • Essen, Germany
  • +2 more
Dec 17, 2020

Gastroenteropancreatic Neuroendocrine Tumor of the Pulmonary ot Gastroenteropancreatic System Trial in Germany (Pasireotide LAR

Completed
  • Gastroenteropancreatic Neuroendocrine Tumor of the Pulmonary ot Gastroenteropancreatic System
  • Pasireotide LAR followed by Pasireotide LAR + Everolimus
  • Everolimus followed by Pasireotide LAR + Everolimus
  • Bad Berka, Germany
  • +3 more
Dec 17, 2020

Cushing Disease Trial in Worldwide (Pasireotide)

Completed
Has Results
  • Cushing Disease
  • Pasireotide
  • Boston, Massachusetts
  • +7 more
May 6, 2021

Hepatic Cirrhosis, Alcoholism Trial in Worldwide (Pasireotide)

Completed
  • Hepatic Cirrhosis
  • Alcoholism
  • Pasireotide
  • Richmond, Virginia
  • +3 more
Dec 17, 2020

Neuroendocrine Tumors Trial in United States (Pasireotide LAR)

Completed
  • Neuroendocrine Tumors
  • Pasireotide LAR
  • Los Angeles, California
  • +3 more
Dec 17, 2020

Castration Resistant Prostate Cancer Trial in Germany (SOM230)

Completed
  • Castration Resistant Prostate Cancer
  • Berlin, Germany
  • +3 more
Dec 17, 2020

Renal Impairment Trial in Berlin, Bloemfontein (SOM230)

Completed
  • Renal Impairment
  • Berlin, Germany
  • +1 more
Dec 17, 2020

Pancreatic Fistula, Pancreatic Tumors Trial in Helsinki (Hydrocortisone, Pasireotide)

Active, not recruiting
  • Pancreatic Fistula
  • Pancreatic Neoplasms
  • Helsinki, Finland
    Helsinki University Central Hospital
Aug 21, 2020

Neuroendocrine Carcinoma of the Lung and Thymus Trial in Worldwide (Pasireotide LAR, Everolimus, Pasireotide LAR and Everolimus

Completed
Has Results
  • Neuroendocrine Carcinoma of the Lung and Thymus
  • Pasireotide LAR
  • +2 more
  • Aarhus, Denmark
  • +35 more
Mar 8, 2021

Carcinoid Tumor, Acromegaly Trial in Worldwide (Pasireotide)

Completed
  • Carcinoid Tumor
  • Acromegaly
  • Pasireotide
  • Los Angeles, California
  • +16 more
Dec 17, 2020

Pasireotide s.c. in Patients With Cushing's Disease

Recruiting
  • Cushings Disease
  • Phoenix, Arizona
  • +70 more
May 19, 2022

Somatostatin Analogs, Polycystic Liver Disease, Autosomal Dominant Polycystic Kidney Disease Trial in Rochester (Pasireotide

Completed
Has Results
  • Somatostatin Analogs
  • +3 more
  • Pasireotide LAR
  • Placebo
  • Rochester, Minnesota
    Mayo Clinic
Apr 30, 2020

Pasireotide on Postoperative Pancreatic Fistulas Following

Completed
  • Surgical Complications
  • Pasireotide 0.9 MG/ML
  • (no location specified)
Feb 21, 2020